Article Details

OriginCell Therapeutics Presents Positive Results of GPC3 CAR-T in HCC Trial at the 2021 ASCO ...

Retrieved on: 2021-06-07 01:52:30

Tags for this article:

Click the tags to see associated articles and topics

OriginCell Therapeutics Presents Positive Results of GPC3 CAR-T in HCC Trial at the 2021 ASCO .... View article details on hiswai:

Excerpt

Ori™Ab is a technology platform that enables the expression of 1011 fully human antibody phage display libraries, 1012 nano antibody libraries, and ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up